Impact of revascularization therapy on intestinal rehabilitation therapy in patients with short bowel syndrome caused by acute mesenteric ischemia with chronic multivessel lesions
10.3760/cma.j.cn113855-20231231-00463
- VernacularTitle:血运重建治疗对伴慢性多血管病变的急性肠系膜缺血导致的短肠综合征患者肠康复治疗效果的影响
- Author:
Yufei XIA
1
;
Xin QI
;
Minyi ZHU
;
Xuejin GAO
;
Li ZHANG
;
Yudong SUN
;
Xinying WANG
Author Information
1. 东南大学医学院，南京 210009
- Keywords:
Mesenteric Ischemia;
Short bowel syndrome;
Rehabilitation research;
Revascularization
- From:
Chinese Journal of General Surgery
2024;39(3):172-182
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate whether intestinal rehabilitation therapy (IRT)could optimize the effectiveness of IRT in patients with short bowel syndrome (SBS) caused by acute mesenteric ischemia (AMI) with chronic multivessel lesions.Methods:Clinical data of 18 hospitalized patients diagnosed with AMI leading to SBS and undergoing IRT at the Eastern Theater General Hospital of the People's Liberation Army from Jan 2012 to Oct 2023 was retrospectively analyzed.Result:Following IRT, the revascularization group showed significantly greater increases in ASMI and grip strength compared to the control group [(0.28±0.26) kg/m 2vs. (0.02±0.21) kg/m 2, P=0.033, and (0.97±0.33) kg vs. (0.48±0.34) kg, P=0.007, respectively]. Similarly, the increase in EN intake was significantly higher in the revascularization group compared to the control group [(572.5±93.6) ml/d vs. (375.2±176.3) ml/d, P=0.012], accompanied by a greater improvement in intestinal nitrogen absorption rate [(25.06±14.06)% vs. (13.84±4.62)%, P=0.034] and a more substantial decrease in GSRS scores [(-15.88±3.94) vs. (-6.33±5.13), P=0.030]. Moreover, there were significant differences in the composition of EN formulations between the two groups after IRT ( P=0.046). Additionally, SF-36 scores at discharge were significantly higher in the revascularization group than that in the control group for five indicators including BP, GH, VT, SF, and MH ( P<0.05). Conclusions:For patients with SBS resulting from AMI by chronic multivessel lesions, revascularization therapy may not leading to higher growth in weight and hematological nutritional indicators during IRT, but it is beneficial for improving muscle function, improving EN absorption, increasing the likelihood of PN independence, relieving gastrointestinal symptoms, and enhancing overall quality of life.
